HCPCS Level IIdrugActive
J1612
Inj glucagon (gvoke) 0.01 mg
BETOS: O1E
Effective: 2025-10-01
Description
Injection, glucagon (gvoke), 0.01 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Gvoke Vialdx
Manufacturer
American Regent, Inc.
HCPCS Dosage
0.01 MG
Billing Units
100.0000
2
NDC Products
opps
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.